These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30579183)

  • 1. Cost-effectiveness and cost-utility analysis of outpatient follow-up frequency in relation to three-year mortality in discharged patients with bipolar disorder.
    Pan YJ; Kuo KH; Chan HY; Yeh LL
    Psychiatry Res; 2019 Feb; 272():61-68. PubMed ID: 30579183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year mortality in relation to early hospitalization and number of outpatient clinic visits in people with newly diagnosed bipolar disorder.
    Pan YJ; Yeh LL; Chen YC; Chan HY
    Gen Hosp Psychiatry; 2016; 43():32-37. PubMed ID: 27796255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare cost, service use and mortality in major psychiatric disorders in Taiwan.
    Pan YJ; Kuo KH; Yeh LL
    J Affect Disord; 2019 Mar; 246():112-120. PubMed ID: 30580196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs associated with attempted suicide among individuals with bipolar disorder.
    Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
    J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bipolar patients treated with long-acting injectable risperidone in Taiwan: A 1-year mirror-image study using a national claims database.
    Hsieh MH; Chuang PY; Wu CS; Chang CJ; Chung PF; Tang CH
    J Affect Disord; 2017 Aug; 218():327-334. PubMed ID: 28494390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effectiveness and cost of a systematic care program for bipolar disorder.
    Simon GE; Ludman EJ; Bauer MS; Unützer J; Operskalski B
    Arch Gen Psychiatry; 2006 May; 63(5):500-8. PubMed ID: 16651507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient Follow-Up Care and Risk of Hospital Readmission in Schizophrenia and Bipolar Disorder.
    Marcus SC; Chuang CC; Ng-Mak DS; Olfson M
    Psychiatr Serv; 2017 Dec; 68(12):1239-1246. PubMed ID: 28669289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost effectiveness of single-level instrumented posterolateral lumbar fusion at 5 years after surgery.
    Glassman SD; Polly DW; Dimar JR; Carreon LY
    Spine (Phila Pa 1976); 2012 Apr; 37(9):769-74. PubMed ID: 20489676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of collaborative clinician visits on postdischarge total cost of care in a polypharmacy population.
    Herges JR; Borah BJ; Moriarty JP; Garrison GM; Gullerud RE; Angstman KB
    Am J Health Syst Pharm; 2020 Oct; 77(22):1859-1865. PubMed ID: 33124654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
    Mittmann N; Au HJ; Tu D; O'Callaghan CJ; Isogai PK; Karapetis CS; Zalcberg JR; Evans WK; Moore MJ; Siddiqui J; Findlay B; Colwell B; Simes J; Gibbs P; Links M; Tebbutt NC; Jonker DJ; ;
    J Natl Cancer Inst; 2009 Sep; 101(17):1182-92. PubMed ID: 19666851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute inpatient treatment, hospitalization course and direct costs in bipolar patients with intellectual disability.
    Wu CS; Desarkar P; Palucka A; Lunsky Y; Liu SK
    Res Dev Disabil; 2013 Nov; 34(11):4062-72. PubMed ID: 24051362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care).
    Maru S; Byrnes J; Carrington MJ; Chan YK; Thompson DR; Stewart S; Scuffham PA;
    Int J Cardiol; 2015 Dec; 201():368-75. PubMed ID: 26310979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insurance expenditures on bipolar disorder: clinical and parity implications.
    Peele PB; Xu Y; Kupfer DJ
    Am J Psychiatry; 2003 Jul; 160(7):1286-90. PubMed ID: 12832243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of depression case management in small practices.
    Gensichen J; Petersen JJ; Von Korff M; Heider D; Baron S; König J; Freytag A; Krauth C; Gerlach FM; König HH
    Br J Psychiatry; 2013 Jun; 202():441-6. PubMed ID: 23580379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
    Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
    Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness Analysis of an Aftercare Service vs Treatment-As-Usual for Patients with Severe Mental Disorders.
    Barfar E; Sharifi V; Amini H; Mottaghipour Y; Yunesian M; Tehranidoost M; Sobhebidari P; Rashidian A
    J Ment Health Policy Econ; 2017 Sep; 20(3):101-110. PubMed ID: 28869209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timely follow-up visits after psychiatric hospitalization and readmission in schizophrenia and bipolar disorder in Japan.
    Okumura Y; Sugiyama N; Noda T
    Psychiatry Res; 2018 Dec; 270():490-495. PubMed ID: 30326432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accountability, utilization and providers for diabetes management in Taiwan, 2000-2009: an analysis of the National Health Insurance database.
    Chang TJ; Jiang YD; Chang CH; Chung CH; Yu NC; Chuang LM
    J Formos Med Assoc; 2012 Nov; 111(11):605-16. PubMed ID: 23217596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions.
    Bagalman E; Muser E; Choi JC; Durden E; Macfadden W; Haskins JT; Dirani R
    Clin Ther; 2011 Oct; 33(10):1381-1390.e4. PubMed ID: 22000656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical costs and vasculometabolic comorbidities among patients with bipolar disorder in Taiwan - a population-based and matched-control study.
    Hsieh MH; Tang CH; Hsieh MH; Lee IH; Lai TJ; Lin YJ; Yang YK
    J Affect Disord; 2012 Dec; 141(2-3):449-56. PubMed ID: 22460055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.